The U.S. Food and Drug Administration approved French drugmaker Sanofi's hemophilia therapy, introducing a new type of ...
The FDA has approved fitusiran, now named Qfitlia, for routine prophylaxis in patients aged 12 and older with hemophilia A or ...
About 3 million people in the U.S. have bleeding disorders. Some types, such as hemophilia, are inherited, meaning a person who has it is born with it. Inherited bleeding disorders are caused by ...
The approval came on the basis of two randomized clinical trials that had 177 adult and pediatric male patients with either ...
When Jessamyn Butler would get nosebleeds as a child, her mother would tell her the length of the bleed was normal, no matter ...
The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare bleeding disorder.
Sanofi's Qfitlia gains FDA approval, offering fewer injections in hemophilia care. Check out my recommendation for SNY stock.
The Great Lakes Hemophilia Foundation will host its 13th annual Milwaukee’s Best Bloody event, offering samples of Bloody Mary cocktails prepared by local bars and restaurants.The ...
MISSION, Kan., March 31, 2025 /PRNewswire/ -- (Family Features) Many people don't think much about whether their blood is clotting properly. However, when you have a bleeding disorder, a condition ...